glp 1 a scam Artificial intelligence-generated videos promoting GLP-1s are all over social media. Do you know the one clear warning sign to tell which ones are scams? New weight-loss scams fueled by

What the Clinical Data Actually Shows The most definitive comparison comes from the SURMOUNT-5 trial, a direct head-to-head study published in the New England Journal of Medicine comparing tirzepatide 10 mg and 15 mg against semaglutide 2.4 mg in adults with obesity but without diabetes

BPC-157 & TB-500 Buy BPC-157 & TB-500 in the UK for research purposes only

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

GLP-1s (semaglutide, etc.) are non-controlled, so those are allowed via telehealthbut you still must meet all the above documentation requirements

In clinical trials, weight loss with GLP-1 medications tends to follow a predictable curve: rapid early losses during drug initiation and dose increases, a gradual slowing and eventual plateau

Race and ethnicity also play a role